泰能作为对内种严重感染的用药，已占据重要地位，并取得满意疗效。我院于1995年1月至9月对重症感染病人35例采用单一素能治疗．疗效确切，副反应少，现分析如下．1．一还资料：本文男24例，女11例；年龄15～90岁，平均5645岁。60岁以上者16例。住院32例，门诊3例。本组35例中 As a medication for severe infections in China, Tainun has taken an important position and achieved satisfactory results. From January 1995 to September 1995, our hospital treated 35 patients with severe infections with a single prime. Efficacy, fewer side effects, are analyzed as follows. 1. A also information: This article 24 males and 11 females; aged 15 to 90 years old, with an average of 5645 years old. Sixteen patients over the age of 60. Inpatient 32 cases, outpatient 3 cases. 35 cases in this group